Adamas to Present at Upcoming June Conferences

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc.,  (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the organization will be participating in two upcoming June conferences:
  • Christopher B. Prentiss, Chief Financial Officer will present at the William Blair 41st Annual Growth Stock Conference on Thursday, June 3 2021 at 11:00 am Eastern Time.
  • Neil F. McFarlane, Chief Executive Officer will participate in a fireside chat at the JMP Securities Life Sciences Conference on Wednesday, June 16 at 3:30 pm Eastern Time.

Both the presentation and the fireside chat will be broadcast live from the investor relations section of the Adamas website at Replays of the events will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit

Source: Adamas Pharmaceuticals, Inc.


Sarah Mathieson
Vice President, Corporate Communications

Peter Vozzo
Managing Director


Source: Adamas Pharmaceuticals, Inc.

Back to news